Valuation: AstraZeneca PLC

Market Cap 259B 222B 207B 190B 356B 24,758B 361B 2,450B 956B 12,437B 972B 950B 41,136B P/E 2026 *
21.5x
P/E 2027 * 18.7x
Enterprise Value 278B 238B 223B 204B 383B 26,607B 388B 2,633B 1,027B 13,366B 1,044B 1,021B 44,209B EV / Sales 2026 *
4.4x
EV / Sales 2027 * 4.05x
Free-Float
96.63%
Yield 2026 *
2%
Yield 2027 * 2.13%
1 day-1.75%
1 week+4.38%
Current month-4.48%
1 month-4.77%
3 months-13.57%
6 months-21.27%
Current year-12.50%
1 week 11,548
Extreme 11548
12,242
1 month 11,404
Extreme 11404
13,164
Current year 10,524
Extreme 10524
15,732
1 year 10,524
Extreme 10524
15,732
3 years 9,461
Extreme 9461
15,732
5 years 8,029
Extreme 8029
15,732
10 years 3,996
Extreme 3996
15,732
Manager TitleAgeSince
Chief Executive Officer 66 01/10/2012
Director of Finance/CFO 52 01/08/2021
Compliance Officer - 01/01/2023
Director TitleAgeSince
Director/Board Member 70 06/04/1999
Director/Board Member 66 01/10/2012
Director/Board Member 65 27/04/2017
Date Insider Type Main position Quantity % Market Cap.
8/6/26 A Free

SVP, Group Controller

2 0.0000%
7/6/26 A Free

See Remarks

2 0.0000%
12/22/25 A Sell

Director

297 0.0000%
Change 5-day change 1-year change 3-year change Capi.($)
-1.62%+4.38%+1.63%+12.24% 259B
-1.06%+6.38%+76.40%+126.87% 1,119B
-0.45%+3.80%+50.73%+64.25% 651B
-0.50%+6.21%+25.81%+80.15% 468B
-1.70%+3.68%+42.05%+41.92% 374B
-1.11%+2.17%+24.54%+40.31% 302B
-0.28%+5.81%+49.57%+70.71% 238B
+0.03%+3.44%-17.66%-53.17% 208B
-0.13%+5.61%+27.32%+89.67% 181B
-0.43%+4.78%+8.46%-23.43% 160B
Average -0.92%+5.13%+28.89%+44.95% 395.98B
Weighted average by Cap. -1.13%+5.37%+42.57%+68.34%

Financials

2026 *2027 *
Net sales 63.25B 54.18B 50.7B 46.41B 87.09B 6,052B 88.24B 599B 234B 3,040B 237B 232B 10,055B 66.84B 57.25B 53.57B 49.04B 92.03B 6,395B 93.25B 633B 247B 3,213B 251B 246B 10,626B
Net income 12.02B 10.3B 9.64B 8.82B 16.55B 1,150B 16.77B 114B 44.4B 578B 45.14B 44.16B 1,911B 13.69B 11.73B 10.97B 10.04B 18.85B 1,310B 19.1B 130B 50.55B 658B 51.4B 50.28B 2,176B
Net Debt 19.33B 16.55B 15.49B 14.18B 26.61B 1,849B 26.96B 183B 71.37B 929B 72.57B 70.99B 3,072B 11.65B 9.98B 9.34B 8.55B 16.04B 1,115B 16.26B 110B 43.03B 560B 43.75B 42.8B 1,852B
Logo AstraZeneca PLC
AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (99.8%). Net sales break down by treatment area between oncology (42.6%), cardiovascular, renal and metabolic diseases (23%), respiratory and autoimmune diseases (14.7%), and other (19.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (0.2). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (22.9%), the United States (40.8%), Americas (6.1%) and Africa/Asia/Australia (22.8%).
Employees
96,100
Date Price Change Volume
24/08/26 GBX 12,068.00 -1.41% 420,573
21/08/26 GBX 12,240.00 +1.26% 2,344,335
20/08/26 GBX 12,088.00 +0.32% 3,149,125
19/08/26 GBX 12,050.00 +2.07% 3,133,515
18/08/26 GBX 11,806.00 +2.13% 3,194,492
Trader
Investor
Global
Quality
ESG MSCI
A
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
24
Last Close Price
166.83USD
Average target price
212.30USD
Spread / Average Target
+27.25%

Quarterly revenue - Rate of surprise